ACC.21 Congress (American College of Cardiology 2021 Congress) (Videos)

قیمت عادی
$70.00
قیمت فروش
$70.00
قیمت عادی
$0
فروخته شده
قیمت واحد
مقدار باید 1 یا بیشتر باشد

کنگره ACC.21 (کنگره کالج قلب و عروق آمریکا 2021) (فیلم ها)

پس از پرداخت دوره را از طریق LIFETIME بارگیری لینک (سرعت سریع) دریافت خواهید کرد

*کنگره کالج آمریکایی قلب و عروق 2021*

ACC.21، تمام تجربه مجازی، تحقیقات و آموزش بالینی دیر شکست را در 11 مسیر یادگیری در یک انجمن تعاملی و تعاملی ارائه می دهد که آخرین به روز رسانی های تغییر عملکرد را در مراقبت ارائه می دهد.

در بیش از 200 جلسه در 11 مسیر یادگیری شرکت کنید که شامل علم دیرشکنی، تحقیقات متحول کننده تمرین و آموزش پیشرفته است که از جلسه علمی سالانه کالج انتظار دارید.

اکسپو را کاوش کنید و درباره آخرین پیشرفت‌ها در داروسازی، تصویربرداری، دستگاه‌ها، فناوری اطلاعات سلامت و خدماتی که برای ارائه مراقبت‌های با کیفیت بالا برای بیماران خود نیاز دارید، اطلاعات بیشتری کسب کنید. با غرفه داران شرکت کننده گپ بزنید تا به سوالات خود پاسخ دهید.

برای 70 به ما بپیوندیدth جلسه سالانه در حالی که از برندگان جوایز 2021 و مشارکت آنها در ACC و این حرفه قدردانی می کنیم، به همراهان و همکاران جدید خوش آمد می گوییم، و رئیس جدید ACC، Dipti Itchhaporia، MD، FACC را به رسمیت می شناسیم.

از 15 تا 17 می ACC.21 برای هزاران نفر از اعضای تیم قلب و عروق از سراسر جهان پخش شد! برای کاوش در تمام آموزش های ACC.21 با دسترسی On Demand وقت بگذارید. بیش از 300 جلسه شامل تحقیقات متحول کننده تمرین و آموزش پیشرفته را تماشا کنید. به‌علاوه، بیش از 3,3000 چکیده الکترونیکی، بیش از 100 غرفه‌دار، و فرصت جشن گرفتن دستاوردهای همکارانمان با Convocation را از دست ندهید. نمونه‌ای از مجموعه‌ای بی‌نظیر از آموزش، زمانی که برای شما راحت است - از خانه، محل کار، یا در حال حرکت - در 11 مسیر یادگیری. ACC.21 شما را در مورد جدیدترین تحقیقات بالینی به روز می کند و خواهید فهمید که چگونه همه اینها بر مراقبت از بیماران شما تأثیر می گذارد.

ACC کنفرانس سالانه شورای کنترل خودکار آمریکا (AACC)، سازمان ملی ایالات متحده عضو فدراسیون بین‌المللی کنترل خودکار (IFAC) است. انجمن ملی و بین‌المللی حامیان ACC عبارتند از: موسسه آمریکایی هوانوردی و فضانوردی (AIAA)، موسسه مهندسین شیمی آمریکا (AIChE)، انجمن مهندسین عمران آمریکا (ASCE)، انجمن مهندسین مکانیک آمریکا (ASME)، کنترل IEEE انجمن سیستم ها (IEEE-CSS)، موسسه تحقیقات عملیات و علوم مدیریت (INFORMS)، انجمن بین المللی اتوماسیون (ISA)، انجمن بین المللی مدل سازی و شبیه سازی (SCS)، و انجمن ریاضیات صنعتی و کاربردی (SIAM).


*مطالب: (297 ویدئو)

| 406 مجله مشترک کالج آمریکایی قلب و عروق انجمن پزشکی آمریکا کارآزمایی های بالینی دیر شکست.ts

| 407 Joint American College of CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts

| 411 Late-Breaking Clinical Trials V.ts

| 908 Highlighted Original Research Multimodality Imaging and the Year in Review.ts

| 910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts

| A Contemporary Understanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis.ts

| A Melting Pot of Clinical Valvular Heart Disease Cases No Cookbook, but a Practical Applications from the Valve Guidelines.ts

| A Practical Approach to Shared Decision Making when Treating Heart Valve Disease.ts

| A Review of the RADIANCE-HTN Global Clinical Trial Program A Focus on the TRIO cohort.ts

| ACC Cardiology Hour.ts

| ACC.21 Highlights in Hypertension.ts

| ACC21-Frequently-Asked-Questions-UPLOADED-May-11-2021.pdf

| Acing the Transition What FITs Need to Know to Launch a Healthy, Successful Career.ts

| Adult Congenital Heart Disease Cases That Stumped Me.ts

| Advanced Nuclear Cardiology Applications in 2021.ts

| Advances and new studies for the treatment of MR with Abbott’s TMV repair and replacement therapies.ts

| Advancing Patient Care Across the Heart Failure Continuum.ts

| Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock.ts

| Anticoagulation Trivia from A to V Management Strategies Across the Board Meeting on Demand.mp4

| Antithrombotic Controversies in the Cath Lab.ts

| Antithrombotic Management in Patients with Atrial Fibrillation Undergoing PCI.ts

| Aortic Valve Interventions Clinical Dilemmas.ts

| Aortic Valve Interventions Expanding Indications.ts

| Application of Dual Source CT in cardiac imaging – a focus on Structural Heart Disease.ts

| Applying the Guidelines For Lipid Management in Special Populations.ts

| Arrhythmogenic Cardiomyopathies Tell Me What I Need to Know.ts

| ASCVD Risk Factors and Beyond.ts

| Atrial Fibrillation Management in Athletes.ts

| Best of JACC Journals & Eugene Braunwald Keynote.ts

| Best Practices of Multimodality Imaging in Percutaneous Mitral Interventions.ts

| Beyond a Broken Heart Multisystem Disease Burden in hATTR Amyloidosis.ts

| Beyond Atrial Fibrillation – Atrial Cardiopathy as a Cause of Cryptogenic Stroke.ts

| Bleeding Reduction Strategies Following PCI.ts

| Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients.ts

| Cardiac CT in Clinical Practice.ts

| Cardiac Culture Medium Current Concepts in Infective Endocarditis.ts

| Cardiac Imaging in Older Adults Overused or Underutilized Practical Points for Clinicians.ts

| Cardiac Point of Care Ultrasound Around the World.ts

| Cardiac Rehab Move to Improve.ts

| Cardio-Oncology Today’s Standard of Practice.ts

| Cardiogenic Shock Progress, Paradigms and Unresolved Problems.ts

| Cardiogenic Shock Teams and Devices for Cardiogenic Shock.ts

| Cardiologist Versus Calcium Unstoppable Force Meets Immovable Object.ts

| Cardiovascular Considerations in Amateur and Professional Athletes.ts

| Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease.ts

| Cardiovascular Imaging to Enhance Prevention.ts

| Caring for the Patient with STEMI in 2021.ts

| Case Based Learning for the Cardiovascular Team.ts

| Cases from the Guidelines for Clinicians.ts

| CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure.ts

| Challenges of Transplantation in Congenital Heart Disease Patients Ethics, Listing Strategy & MCS.ts

| Challenging Cases in Cardio-Oncology.ts

| Chest Pain Evaluation in 2021 Same Problem, New Tools, New Questions.ts

| Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF).ts

| Clinical Trials Research Upping Your Game.ts

| Clinical Trials ThunderDome Who Will Be Crowned Most Impactful.ts

| Complex and High-Risk PCI Case Based Joint Symposium.ts

| Complex Case-Based Decision-Making – The Heart Team in Action A Joint Symposium by TCT.ts

| Complex Dilemmas in Valvular Heart Disease.ts

| Contemporary Aortic Valve Disease Management.ts

| Contemporary Challenges in Cardiac Critical Care Structure, Staffing, Training and Beyond.ts

| Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices.ts

| Controversies in Arrhythmia Therapy.ts

| Controversies in Interventional and Surgical Management of Congenital Heart Disease.ts

| Controversies in the ICU Management of Congenital Heart Disease.ts

| Core Knowledge in Action Essentials of Stable Ischemic Heart Disease.ts

| Core Knowledge in Action Return to the Basics of Aortic Stenosis.ts

| Core Knowledge in Action The Ultimate Guide to Lipids.ts

| Core Knowledge in Action What Everyone Ought To Know About HFpEF.ts

| Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke.ts

| Coronary IVL’s Who, What, Where, When & Why An Introductory Guide for Clinical Practice.ts

| COVID 19 and Heart Failure Lessons Learned and Future Directions.ts

| COVID-19 and Echocardiography – Impact, Imaging, and Innovation.ts

| Critical Clinical Conundrums in Acute Coronary Syndromes.ts

| Current Approaches to Antiplatelet Therapy for PCI in Acute Coronary Syndrome.ts

| Current Controversies And Debates in CAD Imaging.ts

| CVD Prevention in the Post-COVID19 Era2.ts

| Debates in Arrhythmia Management in Congenital Heart Disease.ts

| Debates Should We Tailor Antiplatelet Therapy for PCI.ts

| Debating Controversies in STEMI Care.ts

| Deep Dive I.ts

| Deep Dive II.ts

| Destined to Fail How to Prevent Heart Failure.ts

| Diabesity A Tale of Obesity, Inflammation and Cardiometabolic Risk.ts

| Diabetes and Heart Failure.ts

| Diagnostic Testing in Stable Ischemic Heart Disease Choosing Wisely.ts

| Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease.ts

| Dissecting the Data Discussions on the Management of SCAD.ts

| Doorways To The Heart Valves In Systemic Disease.ts

| Drug Jeopardy Pharmacological Conundrums in Arrhythmia Management.ts

| ECGs With the Experts Practical Considerations For the Cardiovascular Clinician.ts

| Electrical Disorders – Rhythm and Conduction Disorders.ts

| Emerging Technologies in Vascular Disease.ts

| Endovascular Skills Basics to Bailout Techniques.ts

| EP Issues in Cancer Patients – Beyond Heart Failure.ts

| Essential Vascular Pearls for the Cardiovascular Clinician.ts

| Essentials of Atrial Fibrillation Management – Learn From the Experts.ts

| Evolution of Aortic Valve Replacement in Low-Risk Patients.ts

| Expanding Frontiers in Vascular Intervention.ts

| Expanding the Toolkit Tackling Residual Atherogenic Lipid Risk.ts

| Exploring New Synergies Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab.ts

| Featured Clinical Research I.ts

| Featured Clinical Research II.ts

| Featured Clinical Research III.ts

| Fellows Bootcamp Coronary and Peripheral Disease Management – The Best Cases You Have Seen Yet.ts

| Fellows Bootcamp Structural.ts

| FIT Forum Stump the Professor.ts

| FIT Jeopardy Battle of the State Chapters Finals.ts

| Focus on Interventional Complications.ts

| Four Models of Myocardial Disease & Heart Failure – Myocarditis, HFrEF, HFpEF, HCM.ts

| From Controversy to Clarity in Weight Loss Therapies.ts

| Fusion imaging for transcatheter edge-to-edge mitral valve repair.ts

| Gender-Specific Care of Patients with Acute Coronary Syndrome.ts

| Genetics through Geriatrics – CV Prevention Through the Lifespan.ts

| Getting to the Root of Dietary Effects.ts

| Getting Your Life-and-Style Back in CVD.ts

| Global Burden of Cardiovascular Disease in Women.ts

| Global Leadership and Professional Education in the COVID-19 Era.ts

| Great Debates in Vascular Medicine.ts

| Harnessing the Power of Technology Remote Monitoring and Management in HF.ts

| Help LDL.ts

| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI (2).ts

| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI.ts

| Hemodynamics of Heart Failure You Thought You Knew Them.ts

| Heterotaxy Syndrome or Somerism Whose Side Are You On.ts

| Highlighted Original Research Electrophysiology and the Year in Review.ts

| Highlighted Original Research Heart Failure and Cardiomyopathies and the Year in Review.ts

| Highlighted Original Research Interventional and Structural and the Year in Review.ts

| Highlighted Original Research Pediatric and Congenital Heart Disease and the Year in Review.ts

| Highlighted Original Research Prevention and Health Promotion and the Year in Review.ts

| Highlighted Original Research Pulmonary Vascular Disease and the Year in Review.ts

| Highlighted Original Research Valvular Heart Disease and the Year in Review.ts

| Highlighted Original Research Vascular Medicine and the Year in Review.ts

| Holy Estrogen! Sex Disparities in Heart Failure Therapies Biology, Bias or Both.ts

| How Can I Tell If This Aortic Valve Replacement Is Functioning Normally.ts

| How does Paradise Renal Denervation Fit Into Hypertension Treatment Management.ts

| How Much is Too Much Navigating Medication Overload by Medication Deprescribing.ts

| How to be an Effective Mentor & Mentee.ts

| How to Become a Successful Researcher at Every Stage of Your Career.ts

| How to Choose and Optimize Pacing in Patients with Heart Failure Conduction System Pacing and CRT.ts

| How to Deal With Cases That Go From No Problem to Nightmare.ts

| How to Stent a LM Like a Boss Left Main PCI Workshop.ts

| Hypertension Guidelines Do They Vary Across the World as Much as My Blood Pressure Has Today .ts

| Hypertension Management A Future Full of Promises.ts

| I Know the Evidence So How Do I Incorporate Nutrition and Lifestyle in My Clinic.ts

| Imagination is Everything Innovations in the Cath Lab.ts

| Imaging Cardiomyopathies Challenging Cases.ts

| Imaging Decision Making in Everyday Clinical Practice for Coronary Artery Disease.ts

| Imaging of Congenital Heart Disease Seeing Things We Never Saw Before.ts

| Implementing Rhythm Control Guidelines in Atrial Fibrillation The Good, The Bad, and The Ugly.ts

| Indirect Valvular Heart Disease Problems and Perspectives.ts

| Innovative Nutritional and Dietary Approaches for Cardiometabolic Disease.ts

| Insight of BAV Disease from Asia and Western Perspectives.ts

| International Centers of Excellence Todays Solutions for an Improved Tomorrow.ts

| Interventional Challenging Cases II An Interventional & SHD Potpourri Not to Miss.ts

| Interventional Challenging Cases Will Make You Think.ts

| Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts

| Is the Quality of Cardiovascular Research Declining What Research Should Continue to be Pursued.ts

| Jardiance® (empagliflozin) tablets The Impact of EMPA-REG OUTCOME.ts

| Jeopardy.ts

| Journey of the Right Ventricle in Pulmonary Hypertension.ts

| Kick Starting Your Research Career.ts

| Late-Breaking Clinical Trials IV.ts

| Late-Breaking Clinical Trials.ts

| Launching a Successful Career in Academic Cardiology Key Points to Success.ts

| Left Atrial Appendage Occlusion Clinical Challenges.ts

| Left Ventricular Ejection Fraction Past, Present, and Future Role in Heart Failure Care.ts

| Let’s Get Physical! Exercise and Cardiovascular Health.ts

| Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease.ts

| Living in 3D.ts

| Lower Extremity PAD Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes.ts

| Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World.ts

| Managing the Device Patient in 2021 From Cybersecurity, to MRI and Beyond.ts

| Managing Today’s Advanced Heart Failure Patient.ts

| Men Are From Mars, Women Are From Venus Sex-Specific Risk Factors That Enhance CVD Risk.ts

| Minimally Invasive Therapies and Devices in AHF Featuring the 2021.ts

| MINOCA A Show and Tell With the Experts.ts

| Mitral Valve Disease and Cardiac Arrest Innocent Bystander or Guilty As Charged.ts

| Mitral Valve Interventions Percutaneous Mitral Valve Repair.ts

| Mobile ECG Monitoring How Can We Utilize Wearable Data.ts

| Multimodality Cardiac Imaging and Modern Media.ts

| Multimodality Imaging in Cardio-Oncology.ts

| Multimodality Imaging in Challenging Cases of Infective Endocarditis.ts

| Multimodality Imaging of Athletes What Do The New Consensus Statement Teach Us.ts

| Must Know Tips for Publishing in JACC Journals.ts

| Myocarditis and Heart Failure.ts

| New AHAACC Valve Guidelines A Paradigm Shift in Management of Severe Aortic Stenosis.ts

| New and Emerging Breakthrough Medicines for HFrEF! Now What Do We Do.ts

| New Hypertension Therapies in Asian People.ts

| New Innovations in Cardiovascular Imaging Incorporating Artificial Intelligence Into Daily Practice.ts

| New Recommendations on How to Monitor Patients Post TAVRSAVR.ts

| Nuts & Bolts of Pregnancy and Congenital Heart Disease.ts

| Obstructive Sleep Apnea and Cardiovascular Outcomes What do Cardiologists Need to Know.ts

| Off-Beat Topics in Heart Failure Improving Dysfunction By Treating the Rhythm.ts

| Optimizing LDL-C Management in Recent MI Patients A Focus on Multidisciplinary Care Team Approach.ts

| Optimizing the Patient Care Pathway and LDL-C Management in Patients with Recent MI.ts

| Overcoming Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts

| Parenteral Antithrombotic Therapies for ACS and PCI.ts

| PCI in patients with CKD Insights from a nephrology and interventional cardiology partnership.ts

| Perlas practicas en manejo de lipidos.ts

| Perspectives on Pulmonary Hypertension.ts

| Pharmacologic and Lifestyle Management for ISHD Why Disparities in Care Matter.ts

| Pharmacology I Expanding the Cardiovascular Pharmacology Toolbox.ts

| Pharmacology II Tackling the Supersized Epidemic of Cardio-diabetes.ts

| Pharmacology III An Ounce of Prevention is Worth a Pound of Cure – Advances in Cardio-Oncology.ts

| Pharmacotherapy Considerations in Cardio-Obstetrics.ts

| Polite Parlays in Pulmonary Hypertension.ts

| Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis.ts

| Practical Pearls on ASCVD and Lipid Management.ts

| Pre-operative Care for Non-Cardiac Surgery Emerging Strategies and Ongoing Controversies.ts

| Precision in Classification and Treatment of Heart Failure One Size Does Not Fit All.ts

| Precision PCI in the Real World What Do I Use Every Day.ts

| Proarrhythmia Look Outs! From the ICU to the Food We Eat.ts

| Professional Advancement Across the Academic Cardiology Life Course.ts

| Professionalism and Ethics in Cardiology.ts

| Progression of Pulmonary Arterial Hypertension Pharmacotherapy Plainly Played-out in a Patient Case.ts

| Protected PCI Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes.ts

| Pulmonary Hypertension Primer WHO Are the Groups.ts

| Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy.ts

| Rapid Fire Session on Valvular Heart Disease.ts

| Re-imagining the 90-Day High-Risk Period Post-AMI Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization.ts

| Recent Trials in SIHD Translating Results into Clinical Practice.ts

| Registries in Cardiac Imaging How Will they Change Clinical Practice.ts

| Repair Is Not Correction Long Term Follow-up of Surgery for Congenital Heart Disease.ts

| Return To Play What The Experts Would Do.ts

| Reversible Cardiomyopathies Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts

| Right Sided Valve Interventions.ts

| Role of Multimodality Imaging in Diagnosis and Management of Cardiovascular Complications in Patients with COVID-19.ts

| Sex Differences in Arrhythmias.ts

| Shock Teams and Shock Docs.ts

| So You Want To Be a Chief of Cardiology.ts

| Star Wars What Does the Future Hold for EP.ts

| Sticky Situations for Revascularization in SIHD When the Evidence Is Limited but Opinions Are Vast.ts

| Strategies for Bleeding Avoidance After Complex PCI.ts

| Streamlining diagnosis and treatment in chronic coronary artery disease.ts

| Stress Echo Beyond Obstructive CAD.ts

| Stroke Prophylaxis Treating the Untreated.ts

| Structural Complications & How to Deal with Them.ts

| Structural Heart Disease Challenges in 2021 – Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies.ts

| Tackling Cardiometabolic Risk A Case Based Discussion.ts

| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and How DISCUSSION.ts

| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and HowDIAPOSITIVAS.ts

| The Constant Debate TAVR Versus SAVR – One Size Does Not Fit All.ts

| The European Heart Journal’s Year in Cardiovascular Medicine.ts

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 1.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 2.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 4.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 5.mp4

| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand3.mp4

| The Future of Dyslipidemia Management.ts

| The TeleHealth Cardiac Team Challenges and Opportunities.ts

| The Time Has Come For Systematic Screening For Asymptomatic Atrial Fibrillation.ts

| The US-China Consensus on High Efficiency PVI Using RF Energy in Patients with Paroxysmal AF and AF Workflow Sharing.ts

| Thrombosis & Prevention in COVID-19 What Are We Missing.ts

| To Right a Wrong in Heart Failure.ts

| Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology.ts

| Topical Topics in Pulmonary Arterial Hypertension.ts

| Tough Choices Cases in Cardiogenic Shock.ts

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 1.mp4

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 2.mp4

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 3.mp4

| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 4.mp4

| Transcatheter Mitral Valve Replacement Expanding Indications and Trial Update.ts

| Translational Cardiac Anatomy.ts

| Treat the Pump or Treat the Rhythm Let’s Talk About Both.ts

| Treating Comorbidities to Treat Heart Failure Sleep, Exercise, Weight Loss, Iron and More.ts

| Tricuspid Regurgitation No Longer The Forgotten Valve.ts

| Under the Bright Light Debates in Interventional Cardiology.ts

| Understanding the Impact of Lp(a) in ASCVD A focus on added CV risk, guidelines, and testing.ts

| Unfolding the Mysteries of Cardiac Amyloidosis.ts

| Uniquely Bicuspid Valve Two Leaflets and A Tool Kit.ts

| Universal Definition of Heart Failure.ts

| Updates in Management of Hypertrophic Cardiomyopathy.ts

| Use of Direct Oral Anticoagulants in Special Populations Complex Dosing Strategies and Complicated Patients.ts

| Valvular Conundrums Grey Area Cases, What the Experts Think.ts

| VASCEPA® (icosapent ethyl) Elevating the Standard of Care.ts

| Vascular Manifestations of COVID-19 Around the Globe.ts

| Vasculo-Oncology Lessons Learned for Clinical Practice in 2021.ts

| Venous Interventions 2021.ts

| Venous Thromboembolism Current Controversies and Practical Management.ts

| Virtual Outpatient Experience for Cardiac Electrophysiologists High Yield Topics.ts

| Vulnerable Plaques Intervention or Pharmacologic Therapy.ts

| Watchman Transmission.ts

| What Can We Learn From Each Other For Global Heart Failure Care.ts

| What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables.ts

| What’s In a Name Practicalities of the 4th Universal Definition of MI.ts

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 1.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 2.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 3.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 4.mp4

| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 5.mp4

| When Fat Overpowers Muscle Obesity and the HFpEF Epidemic.ts

| Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World 5.ts

| World Heart Federation Featured Research With Year in Review.ts

| Yes, No, Maybe How to Diagnose and Treat INOCA (Ischemia and No Obstructive Coronary Artery Disease) Today.ts

| Your PVI Toolkit.ts

به سایت کامل بروید